Member Info for crumbs

I think scancell know how they did it plus I think they really know how BioNtech are doing it... stepping stones... deals and data and investment and if they all lead to commercially viable products... then either sell to highest bidder or become a pharma yourself

Market to be in... and again due to the numbers of currently 'untreatable' patients the potential only grows as the therapies to treat them appear on the market:

'Market Overview
The global cancer therapy market was valued at USD 136,254.35 million in 2018, and is estimated to be valued at USD 220,701.26 million in 2024, witnessing a CAGR of 8.37%. Certain factors that are driving the market growth include increasing Patient Assistance Programs (PAPs), increasing government initiatives for cancer awareness, rising prevalence of cancer worldwide, and strong R&D initiatives from key players.'

Yes and that is why Kite and Juno got those pricetags... they treated the terminal and cured enough of them to create a new market :)

moditope alone has greater potential than both of those companies as it is not as target restricted plus the cost and toxicity factors make it a potential complete game changer and new market creator.

Ruck, I respect your values based on found figures especially with current sp of 5p and mcap of £22 million......But I do not see the future of scancell like that ...to me the sale prices of Kite and Juno of $11 and $9 billion the probable BioNtech mcap of $4 billion if they get onto the NASDAQ are of more interest as I see that as where we are heading as in we are going to have to have deal/s or be bought out for any products to go anywhere... and those deal/s and buyout values are huge often on preclinical products too...

I know inanaco has his ARM holdings scenario etc... the idea scancell become a big player itself... it is possible of course but even to get to that there has to be huge amounts of incoming money ... the way most do it is deal/s and or other forms of funding....

If you can work out by any formula how products or whole companies that have only small trials data and nothing commercial can be bought by companies for $9 and $11 billion please share it :)

boom boom!

bob perfectly summed up...

Ruck,I don't think snake oil would get through clinical trials these days.... though you never know :)

The science does not need defending it needs commercialising.... and scancell have today admitted again AIM is not the place for such a company and they are sadly right(DE stopped moditope going the private route) ...not the sciences fault or us holders fault but AIM is not a market that values science the likes of BioNtech would never have got to where they are heading with a potential $800 million NASDAQ IPO and $4 billion mcap as an AIM minnow relying on market raises ... AIM will value commercial action though so lets be having it!

I feel a lot of pent up frustration is coming out today in LTH looking at the comments under RG's tweet well actually most of his tweets over the last months :) Totally understand it ...but I'm patiently optimistic, we are in the queue with our emptying jar waiting for jam tomorrow but what is that a sweet smell in the air ahead ...new TCR therapeutics...multiple partnership talks... head and neck replacing sarcomas...moditope patent protected...... things always happening behind the team science curtain.

Indeed I have no friends or family I like enough to let in on it lol... no the point I made which you got was it is not a share at this stage for the faint of heart so could not recommend it to people I know and then watch as their 5p shares went to 2p... you need a stomach and to have really DYOR... I added myself I'm adding and certainly, I think there is a great possibility of none dilutive funding and glory days ahead... Also added as soon as some form of transformational news arrived I would definitely recommend this share to anyone as the potential of scancell being a leader in an emerging market that will is already worth $billions and will be worth $$$$billions is a very real one...

No but at last a bit of positivity..... Let's see what happens

Tommy is moditope IP more protected and more valuable to a potential commercial partner today than it was yesterday?

To create a potentially great buying opportunity if that commercial news is on it's way

That's good hopefully a video and updates included....Maybe things are lining up that are of a commercial nature not saying that is the case of course just a very possible possibility

Thanks There are SCIB1 patients effectively cured by but one product from one platform of one pipeline.. so you know the science is not just lab talk :)

A lot of quiet ISA filling going on today I think

Should say 17 potential cancer targets from one product of one pipeline :) modi2 looking set to get ip global ip protection too... It all has to be commercially tempting to a great many pharma and biotechs hungry for IO assets ...And could we hear a lot more about those 'new TCR therapeutics' by May?... very possibly

Yes was aving a larf ... not discounting a possible market raising at some point but with current sp scancell are unable to raise any meaningful amount beyond keeping the lights on for a few months past current funds running out... CH always conservative with his RNS comments probably due to learning the lesson of his 'near-term' gaff RG being a little looser though in tweeter land some would call that an almighty ramp even! ....the science around modi1 is now pretty much protected just China left and they look to be granting it sometime soon?... so that is 17 potential cancer targets ....

But it means moditope trials... we know of only one trial.. could it be a TCR hint? or possibly modi2 also... could just be RG going off leftfield never to be heard of again too :)

Notice the most important of words 'trials' not just a 'trial' and of course the one we want most of all 'commercialisation'

Close to something?.... risk/reward
1p placing or mega deal/s
:)